-
This is a small U.S.-based clinical trial of 23 adolescent women (ages 14-18) randomized to levonorgestrel-releasing vs Copper T intrauterine device (IUD).
-
The management of a patient with suspected fetal macrosomia remains an enigma. Not being able to come up with a consistent plan of management for macrosomia is compounded by our inability to reliably predict it.
-
Depot medroxyprogesterone acetate (DMPA) is a highly effective progestin-only contraceptive that is widely used by adolescents. DMPA is also associated with suppression of ovarian production of estradiol, and with a decrease in bone density in some users.
-
The primary objective of this retrospective study was to estimate the incidence of genetic counseling referral for ovarian cancer patients who were at high risk for carrying a mutation in BRCA1 or BRCA2.
-
In this issue: Fractures and bisphosphonate therapy, warfarin anticoagulation and influenza vaccine and cotrimoxazole, antiplatelet therapy with clopidogrel and aspirin, FDA Actions.
-
-
-
In March 2010, President Barack Obama signed the Patient Protection and Affordable Care Act into law, setting the wheels in motion for sweeping health care reform. Now that the dust has settled, what are the implications for those who provide reproductive health services, as well as those who receive them?
-
The last time your teen-age male patient came to the adolescent clinic, he left with a bag of male condoms. However, when he returns to be tested for sexually transmitted diseases (STDs), he tells you he hasn't used the condoms. Why?
-
Sexuality is a normal part of adolescent development. Though sexual behaviors can lead to adverse reproductive health outcomes, most adolescents will become sexually active during their teen-age years, which makes interventions that promote or enhance sexual health in adolescents increasingly important.
